Department
Neurosurgery; Neuropathology; Neuroradiology; Research
Document Type
Article
Abstract
INTRODUCTION: Contrast-enhanced MRI (CE-MRI) represents the current mainstay for monitoring treatment response in glioblastoma multiforme (GBM), based on the premise that enlarging lesions reflect increasing tumor burden, treatment failure, and poor prognosis. Unfortunately, irradiating such tumors can induce changes in CE-MRI that mimic tumor recurrence, so called post treatment radiation effect (PTRE), and in fact, both PTRE and tumor re-growth can occur together. Because PTRE represents treatment success, the relative histologic fraction of tumor growth versus PTRE affects survival. Studies suggest that Perfusion MRI (pMRI)-based measures of relative cerebral blood volume (rCBV) can noninvasively estimate histologic tumor fraction to predict clinical outcome. There are several proposed pMRI-based analytic methods, although none have been correlated with overall survival (OS). This study compares how well histologic tumor fraction and OS correlate with several pMRI-based metrics.
METHODS: We recruited previously treated patients with GBM undergoing surgical re-resection for suspected tumor recurrence and calculated preoperative pMRI-based metrics within CE-MRI enhancing lesions: rCBV mean, mode, maximum, width, and a new thresholding metric called pMRI-fractional tumor burden (pMRI-FTB). We correlated all pMRI-based metrics with histologic tumor fraction and OS.
RESULTS: Among 25 recurrent patients with GBM, histologic tumor fraction correlated most strongly with pMRI-FTB (r = 0.82; P < .0001), which was the only imaging metric that correlated with OS (P<.02).
CONCLUSION: The pMRI-FTB metric reliably estimates histologic tumor fraction (i.e., tumor burden) and correlates with OS in the context of recurrent GBM. This technique may offer a promising biomarker of tumor progression and clinical outcome for future clinical trials.
Medical Subject Headings
Adult; Aged; Blood Volume; Brain Neoplasms; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Glioblastoma; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiation Injuries; Survival Rate; Tumor Burden
Publication Date
7-1-2012
Publication Title
Neuro Oncol
ISSN
1523-5866
Volume
14
Issue
7
First Page
919
Last Page
930
PubMed ID
22561797
Digital Object Identifier (DOI)
10.1093/neuonc/nos112
Recommended Citation
Hu, Leland S; Eschbacher, Jennifer M; Heiserman, Joseph E; Dueck, Amylou C; Shapiro, William R; Liu, Seban; Karis, John P; Smith, Kris A; Coons, Stephen W; Nakaji, Peter; Spetzler, Robert F; Feuerstein, Burt G; Debbins, Josef; and Baxter, Leslie C, "Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival." (2012). Neurosurgery. 778.
https://scholar.barrowneuro.org/neurosurgery/778